Table 1 Baseline characteristics of patients according to different SIRI quartiles
Variables | SIRI | p-value | |||
|---|---|---|---|---|---|
1 | 2 | 3 | 4 | ||
Quartile range | ≤ 0.72 | 0.72–1.06 | 1.07–1.62 | > 1.62 | - |
n | 104 | 104.00 | 104 | 104 | - |
Age, years | 66.14 ± 12.28 | 67.10 ± 13.95 | 69.43 ± 12.94 | 72.17 ± 10.72 | 0.003 |
Male, n (%) | 36(34.6%) | 59(56.7%) | 61(58.7%) | 66(63.5%) | < 0.001 |
height(cm) | 165.03 ± 8.42 | 166.77 ± 8.22 | 166.76 ± 8.75 | 167.74 ± 7.70 | 0.124 |
weight(kg) | 72.20 ± 12.09 | 72.57 ± 12.42 | 72.82 ± 11.80 | 73.19 ± 11.18 | 0.944 |
BMI | 26.48 ± 3.74 | 25.97 ± 3.17 | 26.16 ± 3.78 | 26.01 ± 3.62 | 0.733 |
persistent AF, n (%) | 38(36.5%) | 49(47.1%) | 53(51.0%) | 59(56.7%) | 0.029 |
Type 2 diabetes mellitus, n (%) | 23(22.1%) | 28(26.9%) | 32(30.8%) | 34(32.7%) | 0.339 |
Hypertension, n (%) | 61(58.7%) | 58(55.8%) | 57(54.8%) | 71(68.3%) | 0.180 |
Coronary heart disease, n (%) | 46(44.2%) | 47(45.2%) | 48(46.2%) | 52(50.0%) | 0.849 |
Heart failure, n (%) | 9(8.7%) | 12(11.5%) | 16(15.4%) | 30(28.8%) | < 0.001 |
Smoking, n (%) | 18(17.3%) | 24(23.1%) | 22(21.2%) | 27(26.0%) | 0.493 |
Drinking, n (%) | 12(11.5%) | 18(17.3%) | 18(17.3%) | 22(21.2%) | 0.320 |
Medications | |||||
ACEI/ARB/ARNI, n (%) | 33(31.7%) | 36(34.6%) | 31(29.8%) | 43(41.3%) | 0.317 |
β blocker, n (%) | 28(26.9%) | 32(30.8%) | 31(29.8%) | 25(24.0%) | 0.697 |
CCB, n (%) | 26(25.0%) | 20(19.2%) | 25(24.0%) | 36(34.6%) | 0.079 |
Diuretic, n (%) | 13(12.5%) | 12(11.5%) | 12(11.5%) | 17(16.3%) | 0.695 |
Lipid-lowering drugs, n (%) | 22(21.2%) | 14(13.5%) | 23(22.1%) | 27(26.0%) | 0.156 |
NT-proBNP, pg/ml | 373.74(62.45,846.63) | 475.4(221.24,1125.71) | 506.37(211.56,1405.75) | 968.46(325,50,2555.76) | < 0.001 |
TC, mmol/L | 4.27(3.39,5.10) | 4.30(3.53,5.11) | 3.73(3.10,4.64) | 3.55(3.00,4.49) | < 0.001 |
TG, mmol/L | 1.25(0.93,1.69) | 1.21(0.92,1.65) | 1.06(0.82,1.50) | 1.03(0.77,1.41) | 0.008 |
HDL, mmol/L | 1.05(0.93,1.25) | 1.07(0.95,1.21) | 1.03(0.91,1.21) | 1.05(0.84,1.18) | 0.381 |
LDL, mmol/L | 2.53(1.82,3.20) | 2.61(2.09,3.16) | 2.22(1.67,2.82) | 2.03(1.62,2.71) | < 0.001 |
WBC count, ×109/L | 5.26(4.56,6.56) | 6.09(5.33,6.99) | 6.62(5.65,7.60) | 7.65(6.63,9.08) | < 0.001 |
Neutrophils count, ×109/L | 2.77(2.26,3.43) | 3.63(3.05,4.26) | 4.19(3.70,4.86) | 5.68(4.59,6.53) | < 0.001 |
Monocyte count, ×109/L | 0.36(0.29,0.43) | 0.44(0.38,0.52) | 0.51(0.41,0.63) | 0.61(0.48,0.74) | < 0.001 |
Lymphocyte count, ×109/L | 1.98(1.68,2.42) | 1.85(1.51,2.22) | 1.55(1.25,2.12) | 1.37(1.07,1.78) | < 0.001 |
Platelet count, ×109/L | 205.50(166.00,238.75) | 201.00(161.75,236.75) | 206.00(163.75,242.50) | 200.50(164.25,238.750) | 0.912 |
CRP, mg/L, | 0.66(0.50,2.17) | 0.52(0.5,1.93) | 0.50(0.50,2.43) | 1.71(0.50,7.22) | 0.018 |